Home › Thyroid Cancer › Texas
Thyroid Cancer clinical trials in Texas
15 studies for Thyroid Cancer are looking for participants at sites in Texas.
Cities in Texas
DESTINY-PANTUMOUR04
- Research Site, Dallas
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
- MD Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06507878Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
- The University of Texas M. D. Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT07218315Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06959511Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 2 to 25 · All sexes · Updated Jul 24, 2026 · NCT06458036A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated May 27, 2026 · NCT03093116An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
- M D Anderson Cancer Center, Houston
RecruitingPhase 1Healthy volunteers welcome
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT04589624Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06239194Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- M D Anderson Cancer Center, Houston
Recruiting
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT04693377cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 2 to 99 · All sexes · Updated Nov 14, 2025 · NCT05783323Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
- University of Texas Health Science Center, San Antonio
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Oct 15, 2025 · NCT03160274Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Dec 12, 2024 · NCT05668962From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.